Unlicensed Molnupiravir is an Effective Rescue Treatment

Safety was assessed in all participants who took at least one dose of the medication The viral clearance rate was derived under a Bayesian

days after the last dose of molnupiravir Drug Interactions1: No No dosage adjustment is required in patients with renal impairment, and no

molnupiravir dose Patients were randomized to receive molnupiravir 800 mg PO twice daily for 5 days plus usual care or usual care alone The primary endpoint was

molnupiravir ราคา The selection of the suboptimal Molnupiravir dose was based on a dose-response study against the WT strain that we have previously published in